VEDOLIZUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 13 adverse event reports in the FDA FAERS database where VEDOLIZUMAB was used for Psoriasis.
Most Reported Side Effects for VEDOLIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 21,017 | 28.5% | 637 | 5,998 |
| Colitis ulcerative | 13,455 | 18.2% | 155 | 3,107 |
| Crohn's disease | 9,759 | 13.2% | 227 | 3,122 |
| Drug ineffective | 8,424 | 11.4% | 180 | 2,439 |
| Diarrhoea | 7,493 | 10.2% | 399 | 2,536 |
| Abdominal pain | 6,401 | 8.7% | 117 | 2,324 |
| Fatigue | 5,477 | 7.4% | 394 | 1,730 |
| Haematochezia | 5,215 | 7.1% | 8 | 1,046 |
| Frequent bowel movements | 4,527 | 6.1% | 103 | 1,188 |
| Arthralgia | 4,028 | 5.5% | 308 | 1,164 |
| Malaise | 3,684 | 5.0% | 262 | 1,565 |
| Nausea | 3,582 | 4.9% | 304 | 1,456 |
| Headache | 3,574 | 4.8% | 355 | 1,237 |
| Inappropriate schedule of product administration | 3,259 | 4.4% | 70 | 828 |
| Product dose omission issue | 3,078 | 4.2% | 47 | 859 |
Other Indications for VEDOLIZUMAB
Colitis ulcerative (33,987)
Crohn's disease (28,718)
Product used for unknown indication (8,955)
Inflammatory bowel disease (1,342)
Colitis (805)
Colitis microscopic (286)
Proctitis ulcerative (146)
Deep vein thrombosis (139)
Immune-mediated enterocolitis (89)
Pouchitis (86)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)